24-Hour Migraine Quality of Life Questionnaire (24-Hr MQoLQ)
A 24-Hour Migraine Quality of Life Questionnaire (24-Hr MQoLQ) is a PRO assessment to measure the decrease of quality of life of a person within the past 24 hours after suffering of an acute migraine and taking migraine medication.
- Context:
- It can (typically) be 15-item self-administered questionnaire in five domains (work functioning, social functioning, energy/vitality, migraine symptoms, feelings/concerns) evaluated according to a five-point scale by the test subjects.
- …
- Example(s):
- a 24-Hr MQoLQ ePRO,
- …
- Counter-Example(s):
- a Migraine Physical Function Impact Diary (MPFID) ,
- a HEADWORK Questionnaire,
- a Migraine Disability Assessment Score (MIDAS),
- a Migraine Functional Impact Questionnaire (MFIQ),
- a Migraine-Specific Quality of Life Questionnaire (MSQ),
- a Six-Item Headache Impact Test (HIT-6),
- a WHO Disability Assessment Schedule II (WHO-DAS II).
- See: Episodic Migraine (EM), Chronic Migraine (CM), SAFER Eligibility Check, Patient Intervention Questionnaire, Patient Intervention Outcome, Electronic Clinical Outcome Assessment (eCOA) System, Electronic Patient-Reported Outcome (ePRO), Work Productivity and Activity Impairment (WPAI) Measure, International Classification of Headache Disorders (ICHD), Neurological Disorder.
References
2022
- (NINDS, 2022) ⇒ https://commondataelements.ninds.nih.gov/report-viewer/24075/24-Hour%20Migraine%20Quality%20of%20Life%20Questionnaire%20(24-Hr-MQoLQ) Retrieved:2022-2-19.
- QUOTE: The 24-Hour Migraine Quality of Life Questionnaire (24-Hr-MQoLQ) is a 15-item, self-administered questionnaire aimed at assessing the quality of life of migraine sufferers within a 24-hour period after having taken migraine medication, and within the first 24 hours of a migraine attack. The items cover five domains: work, social, energy and vitality, feeling and concerns, and symptoms. This questionnaire is designed to assess the health of specific populations at a point in time.
2021
- (D'Amico et al., 2021) ⇒ Domenico D'Amico, Stewart J. Tepper, Erika Guastafierro, Claudia Toppo, Matilde Leonardi, Licia Grazzi, Paolo Martelletti, and Alberto Raggi (2021)."Mapping Assessments Instruments for Headache Disorders against the ICF Biopsychosocial Model of Health and Disability". In: International journal of environmental research and public health, 18(1). DOI:10.3390/ijerph18010246.
- QUOTE: Published results are mostly connected to migraine, and more specifically to chronic migraine (CM), and obtained through the use of few assessment instruments, namely the Migraine Disability Assessment scale (MIDAS)[1], the six-Item Headache Impact Test (HIT-6)[2], and the Migraine-Specific Quality of Life Questionnaire (MSQ) [3]. There is a lack of information about TTH and poor information about cluster headache (CH) [4], a condition in which most of research was designed using again the HIT-6, MIDAS, and the MSQ(...)
Almost all assessment instruments retrieved in this review have been used in migraine research, with the exclusion of two CH-specific assessments.
The most used tools were MIDAS[1], HIT-6[2], and the MSQ[3], used in 80, 56, and 27 studies, respectively. In addition to this, 11 studies employed an instrument from the WHO Disability Assessment Schedule (WHODAS) family [5],[6] (either the 36 or 12 item version), and 10 studies employed an instrument from the Short-Form (SF) Health Survey family, i.e., the SF-36, SF-12, or SF-8 [7]. The ICF-linked items by domain for each of the assessment tools used in the research papers included in our analysis are reported in Table 2(...)
Other less used tools were the Migraine Functional Impact Questionnaire (MFIQ)[8], the Migraine Physical Function Impact Diary (MFIPD)[9] addressing impact on daily functioning, and the 24-h Migraine Quality of Life Questionnaire (24-h MqoLQ), addressing various dimensions of QoL [10][11]. Finally, the HEADWORK questionnaire[12] was validated on migraine patients, although deemed to be feasible to address work-related problems of other headache patients.
- QUOTE: Published results are mostly connected to migraine, and more specifically to chronic migraine (CM), and obtained through the use of few assessment instruments, namely the Migraine Disability Assessment scale (MIDAS)[1], the six-Item Headache Impact Test (HIT-6)[2], and the Migraine-Specific Quality of Life Questionnaire (MSQ) [3]. There is a lack of information about TTH and poor information about cluster headache (CH) [4], a condition in which most of research was designed using again the HIT-6, MIDAS, and the MSQ(...)
- ↑ 1.0 1.1 Stewart, W.F.; Lipton, R.B.; Kolodner, K.; Liberman, J.; Sawyer, J. "Reliability of the Migraine Disability Assessment Score in A Population-Based Sample of Headache Sufferers". Cephalalgia 1999, 19, 107–114.
- ↑ 2.0 2.1 Kosinski, M.R.; Bayliss, M.; Bjorner, J.; Ware, J.E., Jr.; Garber, W.; Batenhorst, A.; Cady, R.; Dahlöf, C.; Dowson, A.; Tepper, S. A six-item short-form survey for measuring headache impact: The HIT-6™. Qual. Life Res. 2003, 12, 963–974.
- ↑ 3.0 3.1 Martin, B.C.; Pathak, D.S.; Sharfman, M.I.; Adelman, J.U.; Taylor, F.R.; Kwong, W.J.; Jhingran, P. Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache J. Head Face Pain 2000, 40, 204–216.
- ↑ D’Amico, D.; Raggi, A.; Grazzi, L.; Lambru, G. Disability, Quality of Life, and Socioeconomic Burden of Cluster Headache: A Critical Review of Current Evidence and Future Perspectives. Headache J. Head Face Pain 2020, 60, 809–818.
- ↑ Üstün, T.B.; Chatterji, S.; Kostanjsek, N.; Rehm, J.; Kennedy, C.; Epping-Jordan, J.; Saxena, S.; Von Korff, M.; Pull, C. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull. World Health Organ. 2010, 88, 815–823.
- ↑ Garin, O.; Ayuso, J.L.; Almansa, J.; Nieto, M.; Chatterji, S.; Vilagut, G.; Alonso, J.; Cieza, A.; Svestkova, O.; Burger, H.; et al. chronic diseases. Health Qual. Life Outcomes 2010, 8, 51.
- ↑ Ware, J.J. SF-36 Health Survey. Manual and Interpretation Guide; The Health Institute, New England Medical Center: Boston, MA, USA, 1993.
- ↑ Kawata, A.K.; Hareendran, A.; Shaffer, S.; Mannix, S.; Thach, A.; Desai, P.; Mikol, D.D.; Ortmeier, B.; Bayliss, M.; Buse, D.C. Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ). Headache J. Head Face Pain 2019, 59, 1253–1269.
- ↑ Kawata, A.K.; Hsieh, R.; Bender, R.; Shaffer, S.; Revicki, D.A.; Bayliss, M.; Buse, D.C.; Desai, P.; Sapra, S.; Ortmeier, B.; et al. Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary. Headache J. Head Face Pain 2017, 57, 1385–1398.
- ↑ Hartmaier, S.L.; Santanello, N.C.; Epstein, R.S.; Silberstein, S.D. Development of a Brief 24-Hour Migraine-Specific Quality of Life Questionnaire. Headache J. Head Face Pain 1995, 35, 320–329.
- ↑ Santanello, N.C.; Hartmaier, S.L.; Epstein, R.S.; Silberstein, S.D. Validation of a New Quality of Life Questionnaire for Acute Migraine Headache. Headache J. Head Face Pain 1995, 35, 330–337.
- ↑ Raggi, A.; Covelli, V.; Guastafierro, E.; Leonardi, M.; Scaratti, C.; Grazzi, L.; Bartolini, M.; Viticchi, G.; Cevoli, S.; Pierangeli, G.; et al. Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: The HEADWORK questionnaire. J. Headache Pain 2018, 19, 85.
2020
- (Speck et al., 2020) ⇒ Rebecca M. Speck, Ethan M. Collins, Louise Lombard, and David W. Ayer (2020)."A Qualitative Study to Assess the Content Validity of the 24‐Hour Migraine Quality of Life Questionnaire in Patients with Migraine" . In: Headache: The Journal of Head and Face Pain, 60(9), 1982-1994.
- QUOTE: While the primary endpoints in clinical trials for acute treatment of migraine are pain freedom and most bothersome symptom freedom at 2 hours post dose, patient-reported outcome (PRO) measures should be included in clinical trials. One of the PROs that could be included for measuring the health-related quality of life (HRQoL) of patients with migraine is the 24-Hour Migraine Quality of Life Questionnaire (24-Hr MQoLQ).
The 24-Hr MQoLQ was developed in the mid-1990s, prior to release of the Food and Drug Administration (FDA) PRO Guidance regarding the need for evidence to support the content validity of PROs. While qualitative interviews were conducted with patients during the instrument development phase, the sample included only 6 subjects, the only criterion for their selection was willingness to speak to how their life was affected by migraine, and the sociodemographic and clinical characteristics of the sample has not been reported. Therefore, the evidence necessary to demonstrate that the 24-Hr MQoLQ is content valid, a component of demonstrating an instrument is fit-for-purpose, is lacking and further interviews needed among patients with migraine to facilitate its use in future acute treatment clinical trials. In addition, the original 24-Hr MQoLQ was developed for administration via paper-and-pencil. It was converted, with no changes to the content, to an electronic PRO (ePRO) form consistent with data collection practices as recommended in the FDA Guidance for Industry. Though there is a body of evidence supporting the equivalence of electronic and paper PRO administration, there was a desire to obtain instrument-specific evidence to support the usability of the 24-Hr MQoLQ. For these key reasons, a concept elicitation, cognitive debriefing, and usability study was undertaken to: (1) ascertain the migraine-related symptoms and impacts; (2) determine the comprehensiveness and comprehensibility of the 24-Hr MQoLQ items, as well as the appropriateness and understanding of the recall period, response options, and instructions; and (3) assess the usability of the 24-Hr MQoLQ in ePRO form on a hand-held electronic device (i.e., tablet).
- QUOTE: While the primary endpoints in clinical trials for acute treatment of migraine are pain freedom and most bothersome symptom freedom at 2 hours post dose, patient-reported outcome (PRO) measures should be included in clinical trials. One of the PROs that could be included for measuring the health-related quality of life (HRQoL) of patients with migraine is the 24-Hour Migraine Quality of Life Questionnaire (24-Hr MQoLQ).
1995
- (Hartmaier et al., 1995) ⇒ Susan L. Hartmaier, Nancy C. Santanello, Robert S. Epstein, and Stephen D. Silberstein (1995). "Development of a Brief 24-Hour Migraine-Specific Quality of Life Questionnaire". In: Headache: The Journal of Head and Face Pain, 35(6), 320-329. DOI:10.1111/j.1526-4610.1995.hed3506320.x.
- QUOTE: The objective of this study was to develop a questionnaire to assess the short-term quality of life decrements associated with an acute migraine headache attack. A total of 101 potential quality of life items were generated by interviewing migraineurs and migraine specialists and reviewing the literature. To reduce the items, 76 migraineurs (18 years and older) were asked to identify which of the 101 items affected their quality of life in the 24 hours following onset of a migraine and to rate them on a five-point scale from “not very important” to “extremely important.” Reduction of the 101 items to a 15-item questionnaire was performed by evaluating the results of subject-perceived importance (number of times an item was chosen x mean importance score) in combination with principal components analysis. Five domains were identified: (1) work functioning, (2) social functioning, (3) energy/ vitality, (4) migraine headache symptoms, and (5) feelings and concerns. Each domain has three items and the correlation between the five domains, as measured by the Spearman correlation coefficient, ranged from 0.08 to 0.38 suggesting minimal overlap. The brief migraine quality of life questionnaire was pilot-tested in two groups of 10 migraineurs and revised to improve clarity.